Recombinant human growth hormone (GH) is approved for use in the treatment of children with various aetiologies, including growth hormone deficiency (GHD), Turner syndrome (TS) and born small for gestational age (SGA) with no catch-up growth (1, 2, 3). The gene discussed is GH1; the disease is Turner syndrome.